tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts
PremiumCompany AnnouncementsQ32 Bio Inc. Reports Continued Losses Amid Development Efforts
3M ago
Q32 Bio Appoints New Interim Chief Medical Officer
Premium
Company Announcements
Q32 Bio Appoints New Interim Chief Medical Officer
4M ago
Q32 Bio chief medical officer Jason Campagna to depart
Premium
The Fly
Q32 Bio chief medical officer Jason Campagna to depart
4M ago
Q32 Bio Board Member Mark Iwicki Resigns
PremiumCompany AnnouncementsQ32 Bio Board Member Mark Iwicki Resigns
6M ago
Q32 Bio doses first patient in both parts of SIGNAL-AA trial
Premium
The Fly
Q32 Bio doses first patient in both parts of SIGNAL-AA trial
7M ago
Q32 Bio price target lowered to $15 from $16 at Wells Fargo
Premium
The Fly
Q32 Bio price target lowered to $15 from $16 at Wells Fargo
8M ago
IBM initiated, Southwest upgraded: Wall Street’s top analyst calls
PremiumThe FlyIBM initiated, Southwest upgraded: Wall Street’s top analyst calls
9M ago
Q32 Bio downgraded to Market Perform from Outperform at BMO Capital
Premium
The Fly
Q32 Bio downgraded to Market Perform from Outperform at BMO Capital
9M ago
Q32 Bio downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Q32 Bio downgraded to Neutral from Overweight at Piper Sandler
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100